Key Events This Week
18 May: Stock opens at Rs.632.35, down 1.10% amid broader market weakness
19 May: Price rebounds sharply, gaining 2.27% to Rs.646.70
20 May: Strong quarterly results announced; stock closes at Rs.651.80 (+0.79%)
21 May: Profit concerns weigh; stock falls 3.80% to Rs.627.00
22 May: Recovery rally lifts stock 4.27% to Rs.653.75
Are Healthcare Global Enterprises Ltd latest results good or bad?
2026-05-21 19:28:25Healthcare Global Enterprises Ltd's latest financial results for the quarter ended March 2026 present a complex picture. The company achieved consolidated net sales of ₹652.33 crores, reflecting a year-on-year growth of 11.48%. This indicates a strong revenue performance, marking an all-time quarterly high and showcasing the company's ability to attract patients in the growing oncology market. However, this revenue growth contrasts sharply with the company's net profit, which fell to ₹2.17 crores, a significant decline of 70.52% compared to the previous year. This drastic reduction raises concerns about the company's profitability and its ability to convert revenue into net earnings. The operating margin, while improved to 19.23%, suggests better operational efficiency but does not alleviate the issues surrounding net profit. The financial data also highlights challenges related to the company's capital s...
Read full news article
Healthcare Global Q4 FY26: Profit Collapses 70% Despite Revenue Growth, Valuation Concerns Mount
2026-05-20 19:33:20Healthcare Global Enterprises Ltd., India's leading cancer care chain, reported a disappointing fourth quarter for fiscal year 2026, with consolidated net profit plummeting 70.52% year-on-year to ₹2.17 crores despite recording its highest-ever quarterly revenue. The stark contrast between topline growth and bottom-line deterioration has raised serious questions about operational efficiency and profitability sustainability at a time when the stock trades at an eye-watering valuation of 167 times trailing earnings.
Read full news article











